News

We recently announced that we are joining forces with Muscular Dystrophy UK (MDUK) to find novel therapies for facioscapulohumeral muscular dystrophy (FSHD) – a genetic condition that causes muscle-weakening and wasting in the face, shoulder blades and upper arms. We caught up with Dr Kate Adcock, Director of Research and Innovation at MDUK to learn … Continued

Cambridge UK – 15 July 2020 – Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease treatments at scale, today announced its Rare Treatment Accelerator Programme (RTA) partnership with Muscular Dystrophy UK (MDUK). The RTA collaboration will initially focus on finding novel therapies for facioscapulohumeral muscular dystrophy (FSHD) – a … Continued